JPS50148349A - - Google Patents

Info

Publication number
JPS50148349A
JPS50148349A JP50045924A JP4592475A JPS50148349A JP S50148349 A JPS50148349 A JP S50148349A JP 50045924 A JP50045924 A JP 50045924A JP 4592475 A JP4592475 A JP 4592475A JP S50148349 A JPS50148349 A JP S50148349A
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP50045924A
Other languages
Japanese (ja)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of JPS50148349A publication Critical patent/JPS50148349A/ja
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D331/00—Heterocyclic compounds containing rings of less than five members, having one sulfur atom as the only ring hetero atom
    • C07D331/04—Four-membered rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/46—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings substituted on the ring sulfur atom
    • C07D333/48—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings substituted on the ring sulfur atom by oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
JP50045924A 1974-04-17 1975-04-17 Pending JPS50148349A (2)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US46169974A 1974-04-17 1974-04-17
US05/555,307 US4009847A (en) 1974-04-17 1975-03-11 1-Tertiary-alkyl-3-(substituted thienyl)ureas and 1-tertiary-alkyl-3-(substituted thietyl)ureas as antihypertensive agents

Publications (1)

Publication Number Publication Date
JPS50148349A true JPS50148349A (2) 1975-11-27

Family

ID=27040095

Family Applications (1)

Application Number Title Priority Date Filing Date
JP50045924A Pending JPS50148349A (2) 1974-04-17 1975-04-17

Country Status (21)

Country Link
US (1) US4009847A (2)
JP (1) JPS50148349A (2)
AR (1) AR208545A1 (2)
CA (1) CA1047042A (2)
CH (1) CH611292A5 (2)
DD (1) DD117223A5 (2)
DE (1) DE2516554A1 (2)
DK (1) DK164175A (2)
ES (1) ES436648A1 (2)
FI (1) FI751128A7 (2)
FR (1) FR2267773B1 (2)
GB (1) GB1461209A (2)
HU (1) HU173052B (2)
IE (1) IE41143B1 (2)
IL (1) IL47095A (2)
LU (1) LU72306A1 (2)
NL (1) NL7504570A (2)
NO (1) NO144071C (2)
PH (1) PH11722A (2)
SE (1) SE417965B (2)
YU (1) YU96075A (2)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4156738A (en) * 1977-10-07 1979-05-29 E. I. Du Pont De Nemours And Company Ureidonitriles useful as antihypertensives
US6187799B1 (en) * 1997-05-23 2001-02-13 Onyx Pharmaceuticals Inhibition of raf kinase activity using aryl ureas
US6344476B1 (en) * 1997-05-23 2002-02-05 Bayer Corporation Inhibition of p38 kinase activity by aryl ureas
US7517880B2 (en) 1997-12-22 2009-04-14 Bayer Pharmaceuticals Corporation Inhibition of p38 kinase using symmetrical and unsymmetrical diphenyl ureas
US7329670B1 (en) 1997-12-22 2008-02-12 Bayer Pharmaceuticals Corporation Inhibition of RAF kinase using aryl and heteroaryl substituted heterocyclic ureas
US20080300281A1 (en) * 1997-12-22 2008-12-04 Jacques Dumas Inhibition of p38 Kinase Activity Using Aryl and Heteroaryl Substituted Heterocyclic Ureas
US20080269265A1 (en) * 1998-12-22 2008-10-30 Scott Miller Inhibition Of Raf Kinase Using Symmetrical And Unsymmetrical Substituted Diphenyl Ureas
CA2359244C (en) * 1999-01-13 2013-10-08 Bayer Healthcare Llc .omega.-carboxy aryl substituted diphenyl ureas as p38 kinase inhibitors
US7351834B1 (en) * 1999-01-13 2008-04-01 Bayer Pharmaceuticals Corporation ω-Carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
US8124630B2 (en) 1999-01-13 2012-02-28 Bayer Healthcare Llc ω-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
EP1140840B1 (en) 1999-01-13 2006-03-22 Bayer Pharmaceuticals Corp. -g(v)-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
US7928239B2 (en) 1999-01-13 2011-04-19 Bayer Healthcare Llc Inhibition of RAF kinase using quinolyl, isoquinolyl or pyridyl ureas
US7235576B1 (en) 2001-01-12 2007-06-26 Bayer Pharmaceuticals Corporation Omega-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
US7371763B2 (en) * 2001-04-20 2008-05-13 Bayer Pharmaceuticals Corporation Inhibition of raf kinase using quinolyl, isoquinolyl or pyridyl ureas
AU2002351196A1 (en) * 2001-12-03 2003-06-17 Bayer Pharmaceuticals Corporation Aryl urea compounds in combination with other cytostatic or cytotoxic agents for treating human cancers
US20080108672A1 (en) * 2002-01-11 2008-05-08 Bernd Riedl Omega-Carboxyaryl Substituted Diphenyl Ureas As Raf Kinase Inhibitors
US20030216396A1 (en) * 2002-02-11 2003-11-20 Bayer Corporation Pyridine, quinoline, and isoquinoline N-oxides as kinase inhibitors
WO2003068223A1 (en) * 2002-02-11 2003-08-21 Bayer Corporation Aryl ureas with raf kinase and angiogenesis inhibiting activity
SI1580188T1 (sl) * 2002-02-11 2012-02-29 Bayer Healthcare Llc Aril sečnine kot kinazni inhibitorji
EP2324825A1 (en) * 2002-02-11 2011-05-25 Bayer Healthcare LLC Aryl ureas with angiogenesis inhibiting activity
UY28213A1 (es) * 2003-02-28 2004-09-30 Bayer Pharmaceuticals Corp Nuevos derivados de cianopiridina útiles en el tratamiento de cáncer y otros trastornos.
DE602004007382T2 (de) * 2003-05-20 2008-04-17 Bayer Pharmaceuticals Corp., West Haven Diaryl-harnstoffe für durch pdgfr vermittelte krankheiten
DK1663978T3 (da) * 2003-07-23 2008-04-07 Bayer Pharmaceuticals Corp Fluorsubstitueret omega-carboxyaryl-diphenylurinstof til behandling og forebyggelse af sygdomme og lidelser
JP2007535565A (ja) * 2004-04-30 2007-12-06 バイエル ファーマシューティカルス コーポレーション 癌の治療に有用な置換ピラゾリル尿素誘導体

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH452475A (de) * 1965-05-20 1968-05-31 Bayer Ag Verfahren zum Färben und Bedrucken von synthetischem Textilmaterial mit Anthrachinonfarbstoffen

Also Published As

Publication number Publication date
CA1047042A (en) 1979-01-23
IL47095A0 (en) 1975-06-25
FI751128A7 (2) 1975-10-18
HU173052B (hu) 1979-02-28
LU72306A1 (2) 1976-03-17
YU96075A (en) 1983-04-27
SE417965B (sv) 1981-04-27
IL47095A (en) 1978-03-10
AR208545A1 (es) 1977-02-15
NO144071C (no) 1981-06-17
IE41143L (en) 1975-10-17
PH11722A (en) 1978-05-30
NO144071B (no) 1981-03-09
DK164175A (da) 1975-10-18
NO751351L (2) 1975-10-20
ES436648A1 (es) 1977-08-01
SE7503523L (sv) 1975-10-20
NL7504570A (nl) 1975-10-21
DE2516554A1 (de) 1975-10-30
FR2267773B1 (2) 1978-08-18
US4009847A (en) 1977-03-01
CH611292A5 (2) 1979-05-31
AU8013575A (en) 1976-10-21
FR2267773A1 (2) 1975-11-14
GB1461209A (en) 1977-01-13
DD117223A5 (2) 1976-01-05
IE41143B1 (en) 1979-10-24

Similar Documents

Publication Publication Date Title
FR2267773B1 (2)
FR2270200B1 (2)
AU495870B2 (2)
AU7470174A (2)
CS166863B1 (2)
CH583050A5 (2)
CH592458A5 (2)
CH576885A5 (2)
BG20905A1 (2)
CH600546A5 (2)
BG20146A1 (2)
CH600376A5 (2)
CH600478A5 (2)
CH593231A5 (2)
CH602885A5 (2)
CH581249A5 (2)
CH587739A5 (2)
CH571078A5 (2)
CH590469A5 (2)
CH586445A5 (2)
BG19638A1 (2)
CH604541A5 (2)
CH594277A5 (2)
CH587669A5 (2)
CH583949A5 (2)